Rhythm Pharmaceuticals Inc (RYTM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.61% 57.25	51.30	48.50	32.70	41.83
Cost Of Revenue	12.68% 4.802	5.499	5.543	3.648	3.787
Gross Profit	14.52% 52.45	45.80	42.96	29.06	38.04
Operating Expenses	1.08% 99.51	98.45	88.25	76.06	79.30
Benefits Costs and Expenses	0.67% 104.79	104.09	94.80	82.12	85.21
Costs And Expenses	0.35% 104.32	103.95	93.80	79.71	83.08
Operating Income/Loss	10.62% -47.06	-52.65	-45.30	-47.00	-41.26
Nonoperating Income/Loss	237.86% -0.473	-0.14	-0.999	-2.414	-2.127
Income/Loss From Continuing Operations Before Tax	9.96% -47.54	-52.79	-46.30	-49.42	-43.38
Income Tax Expense/Benefit	127.93% -0.031	0.111	0.337	0.08	-0.09
Income/Loss From Continuing Operations After Tax	10.21% -47.51	-52.90	-46.63	-49.50	-43.29
Net Income/Loss	10.21% -47.51	-52.90	-46.63	-49.50	-43.29
Preferred Stock Dividends And Other Adjustments	3.13% 1.332	1.375	-	-	1.339
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.04% 0.6378	66.26	63.68	63.06	0.2019
Diluted Average Shares	99.04% 0.6378	66.26	63.68	63.06	0.2019
Basic Earnings Per Share	10.98% -0.73	-0.82	-0.75	-0.81	-0.72
Diluted Earnings Per Share	10.98% -0.73	-0.82	-0.75	-0.81	-0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	3.13% 1.332	1.375	-	-	1.339

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%